BioCentury
ARTICLE | Company News

Lundbeck sales and marketing update

September 14, 2015 7:00 AM UTC

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in an early benefit assessment that Brintellix vortioxetine from H. Lundbeck has no added benefit in patients with major dep...